Online citations, reference lists, and bibliographies.
← Back to Search

Independent β-arrestin 2 And G Protein-mediated Pathways For Angiotensin II Activation Of Extracellular Signal-regulated Kinases 1 And 2

Huijun Wei, Seungkirl Ahn, S. Shenoy, S. Karnik, L. Hunyady, L. Luttrell, R. Lefkowitz
Published 2003 · Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Stimulation of a mutant angiotensin type 1A receptor (DRY/AAY) with angiotensin II (Ang II) or of a wild-type receptor with an Ang II analog ([sarcosine1,Ile4,Ile8]Ang II) fails to activate classical heterotrimeric G protein signaling but does lead to recruitment of β-arrestin 2-GFP and activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) (maximum stimulation ≈50% of wild type). This G protein-independent activation of mitogen-activated protein kinase is abolished by depletion of cellular β-arrestin 2 but is unaffected by the PKC inhibitor Ro-31-8425. In parallel, stimulation of the wild-type angiotensin type 1A receptor with Ang II robustly stimulates ERK1/2 activation with ≈60% of the response blocked by the PKC inhibitor (G protein dependent) and the rest of the response blocked by depletion of cellular β-arrestin 2 by small interfering RNA (β-arrestin dependent). These findings imply the existence of independent G protein- and β-arrestin 2-mediated pathways leading to ERK1/2 activation and the existence of distinct “active” conformations of a seven-membrane-spanning receptor coupled to each.
This paper references
10.1016/s0021-9258(18)45992-3
Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis.
S. Cotecchia (1992)
Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
K. Crawford (1992)
10.1126/SCIENCE.1325672
Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.
J. Pitcher (1992)
10.1074/jbc.271.41.25406
Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin*
S. Acharya (1996)
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
S. Laporte (1996)
10.1210/ENDO.139.4.5865
Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells.
Y. Tian (1998)
10.1126/SCIENCE.283.5402.655
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
L. Luttrell (1999)
10.1074/JBC.M910348199
Differential Affinities of Visual Arrestin, βArrestin1, and βArrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of Receptors*
R. Oakley (2000)
10.1073/PNAS.190276697
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.
K. Defea (2000)
Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
A. Scheer (2000)
10.1124/MOL.58.6.1230
The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists.
C. Watson (2000)
10.1074/jbc.C000314200
Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved “DRY” Sequence*
T. A. Bennett (2000)
The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.
A. Alewijnse (2000)
10.1083/JCB.148.6.1267
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
K. Defea (2000)
10.1126/SCIENCE.290.5496.1574
Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
P. McDonald (2000)
10.1096/fj.00-0438rev
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
T. Kenakin (2001)
10.1016/S0955-0674(00)00190-3
Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.
W. Miller (2001)
10.1073/pnas.041604898
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
L. Luttrell (2001)
10.1038/sj.onc.1204184
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades
K. L. Pierce (2001)
10.1016/S0968-0004(01)01804-7
Signaling at zero G: G-protein-independent functions for 7-TM receptors.
J. Brzostowski (2001)
10.1126/SCIENCE.1074683
Targeting of Cyclic AMP Degradation to β2-Adrenergic Receptors by β-Arrestins
S. Perry (2002)
10.1161/01.RES.0000037000.74258.03
Regulation of G protein-coupled receptor signaling by scaffold proteins.
R. A. Hall (2002)
10.1124/MOL.61.4.768
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.
Alice C Holloway (2002)
10.1074/JBC.M106457200
β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation*
A. Tohgo (2002)
10.1074/JBC.M109221200
AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs*
K. Seta (2002)
10.1074/JBC.M212231200
The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation*
A. Tohgo (2003)
10.1016/S0006-2952(03)00257-0
Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways.
J. Hines (2003)
10.1210/EN.2002-0135
The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling.
Z. Gáborik (2003)
10.1126/SCIENCE.1082348
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
D. Lodowski (2003)
10.1073/pnas.262789099
Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference
Seungkirl Ahn (2003)



This paper is referenced by
10.3390/cells10071752
Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
C. Zanza (2021)
10.1016/j.cellsig.2021.109955
Conceptual and experimental issues in biased agonism.
H. O. Onaran (2021)
10.1016/j.bbrc.2021.01.054
Anti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway.
Yingxuan Wang (2021)
10.1101/2021.01.28.427950
Vasopressin V2 is a promiscuous G protein-coupled receptor that is biased by its peptide ligands
F. Heydenreich (2021)
10.34067/KID.0005462020
G protein- and β-arrestin Signaling Profiles of Endothelin Derivatives at the Type A Endothelin Receptor
Xinyu Xiong (2021)
10.1101/2021.06.21.449162
Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses
R. Schulz (2021)
10.1007/s12272-021-01320-y
Mechanistic diversity involved in the desensitization of G protein-coupled receptors.
Ningning Sun (2021)
10.1161/CIRCRESAHA.120.318447
Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension
Xiaomin Song (2021)
10.1016/B978-0-12-819460-7.00096-7
Receptors | Angiotensin Receptors
Triveni R Pardhi (2021)
10.1016/B978-0-12-819801-8.00021-1
β-Arrestins and Endocrine-Related GPCRs
Francesco De Pascali (2021)
10.1038/s41418-020-00704-9
Opposing functions of β-arrestin 1 and 2 in Parkinson’s disease via microglia inflammation and Nprl3
Yinquan Fang (2021)
10.1038/s41598-021-80974-6
Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
Saber Yari Bostanabad (2021)
10.3390/ijms22136704
The LPA3 Receptor: Regulation and Activation of Signaling Pathways
K. H. Solís (2021)
10.1016/j.peptides.2021.170529
Modulation of the rat angiotensin type 1a receptor by an upstream short open reading frame
Parnika S Kadam (2021)
Arrestin-dependent and -independent internalization of GPCRs-methods, mechanisms and implications on cell signaling
Ee Von Moo (2021)
10.1007/164_2021_435
Pharmacology of T2R Mediated Host-Microbe Interactions.
M. Medapati (2021)
10.1038/s41598-021-88601-0
Mixture interactions at mammalian olfactory receptors are dependent on the cellular environment
E. Corey (2021)
10.3389/fphar.2021.630548
The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
Yunlu Jiang (2021)
10.3389/fphar.2021.734917
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
Kanika Verma (2021)
10.1007/s00018-020-03471-5
Beta-arrestins operate an on/off control switch for focal adhesion kinase activity
R. Alexander (2020)
10.1101/2020.01.21.913772
Functional anatomy of the full length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis
Bryan S. Stephens (2020)
10.1016/j.tips.2020.11.001
The Potential of 19F NMR Application in GPCR Biased Drug Discovery.
Xudong Wang (2020)
10.1038/s41598-020-58421-9
A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework
S. Hoare (2020)
10.1101/2020.09.09.289280
Myogenic Vasoconstriction Requires Canonical Gq/11 Signaling of the Angiotensin II Type 1a Receptor in the Murine Vasculature
Yingqiu Cui (2020)
10.1016/j.bioorg.2020.103596
Cell active and functionally-relevant small-molecule agonists of calcitonin receptor.
Shuai Zhao (2020)
10.1016/j.bcp.2020.113910
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
L. Vasudevan (2020)
10.1016/j.str.2020.06.002
Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide.
K. Min (2020)
10.15252/embr.201949886
Key phosphorylation sites in GPCRs orchestrate the contribution of β‐Arrestin 1 in ERK1/2 activation
Mithu Baidya (2020)
10.1161/HYPERTENSIONAHA.120.15793
β-Arrestin-Biased Agonist Targeting the Brain AT1R (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.
M. Zanaty (2020)
10.1016/j.cellsig.2020.109865
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonists.
Monica Patel (2020)
10.1016/b978-0-12-816228-6.00020-9
Angiotensin II receptors
K. D. Singh (2020)
10.1016/j.phrs.2020.105124
Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function.
L. Belkacemi (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar